客戶文獻(xiàn)
[1] Journal of Experimental & Clinical Cancer Research. (IF=11.4). Wanzhen Zhuang, et al. (2024). Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression. 【miRNA mimics & inhibitor，siRNA，雙熒光素酶報(bào)告質(zhì)粒┃肺癌，miRNA抑癌】.
[2] Cell Death & Disease. (IF=8.1). Junfan Pan, et al. (2024). CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation. 【過表達(dá)慢病毒┃肺腺癌，葡萄糖代謝】.
[3] Journal of Translational Medicine. (IF=6.1). Xingyong Chen, et al. (2023). LMP2 deficiency causes abnormal metabolism, oxidative stress, neuroinflammation, myelin loss and neurobehavioral dysfunctions. 【血常規(guī)和血液生化┃神經(jīng)炎癥，氧化應(yīng)激】.
[4] Cell Death Discovery. (IF=6.1). Jingying Wu, et al. (2023). TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis. 【RNAi慢病毒┃肌肉減少癥，TNF-α】.
[5] Cell Death Discovery. (IF=6.1). Mingshu Tu, et al. (2023). NSG1 promotes glycolytic metabolism to enhance esophageal squamous cell carcinoma EMT process by upregulating TGF-β. 【siRNA┃食管鱗狀細(xì)胞癌，EMT】.
[6] Neural Regeneration Research. (IF=5.9). Xingyong Chen, et al. (2024). Activation of the Wnt/β-catenin/CYP1B1 pathway alleviates oxidative stress and protects the blood-brain barrier under cerebral ischemia/reperfusion conditions. 【過表達(dá)慢病毒┃腦缺血再灌注，氧化應(yīng)激】.
[7] Journal of Orthopaedic Translation. (IF=5.9). Hanhao Dai, et al. (2024). Inhibiting uptake of extracellular vesicles derived from senescent bone marrow mesenchymal stem cells by muscle satellite cells attenuates sarcopenia. 【siRNA┃肌肉減少癥，細(xì)胞外囊泡】.
[8] Frontiers in Immunology. (IF=5.7). Yaqi Zhong, et al. (2024). Deciphering colorectal cancer radioresistance and immune microenvironment: unraveling the role of EIF5A through single-cell RNA sequencing and machine learning. 【siRNA，shRNA慢病毒┃結(jié)直腸癌，放療耐受性】.
[9] Frontiers in Immunology. (IF=5.7). Huadong Wu, et al. (2023). TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion. 【過表達(dá)質(zhì)粒┃頭頸鱗癌，免疫逃逸】.
[10] Journal of Cellular and Molecular Medicine. (IF=4.3). Peng Yang, et al. (2023). miR‐221‐3p targets Ang‐2 to inhibit the transformation of HCMECs to tip cells. 【過表達(dá)質(zhì)粒和shRNA質(zhì)粒┃腦微血管內(nèi)皮細(xì)胞，miRNA】.
[11] Cancer Cell International. (IF=5.3). Kai Ye, et al. (2024). E3 ubiquitin ligase BTBD3 inhibits tumorigenesis of colorectal cancer by regulating the TYRO3/Wnt/β-catenin signaling axis. 【過表達(dá)和RNAi慢病毒結(jié)┃直腸癌，泛素化】.
[12] Molecular Neurobiology. (IF=4.6). Taotao Lu, et al. (2024). Alisol A exerts neuroprotective effects against HFD-induced pathological brain aging via the SIRT3-NF-κB/MAPK pathway. 【shRNA慢病毒┃腦老化，炎癥】.
[13] Respiratory Research. (IF=4.1). Yun Ding, et al. (2021). CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia–reperfusion injury in vivo and in vitro. 【重組腺相關(guān)病毒┃肺動脈高壓，EETs】.
[14] Aging (Albany NY). (IF=3.9). Xuyang Wang, et al. (2023). PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest. 【shRNA質(zhì)粒┃肝細(xì)胞癌，免疫微環(huán)境】.
[15] Scientific Reports. (IF=3.8). Zheng Zheng, et al. (2021). MicroRNA-513b-5p targets COL1A1 and COL1A2 associated with the formation and rupture of intracranial aneurysm. 【KTC-1細(xì)胞系，miRNA inhibitor和miRNA mimic合成┃顱內(nèi)動脈瘤】.
[16] Frontiers in Oncology. (IF=3.5). Lijuan Ke, et al. (2022). ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma. 【HT22細(xì)胞系┃甲狀腺癌】.
[17] BMC Cancer. (IF=3.4). Qiwei Yao, et al. (2022). CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro. 【siRNA┃肺腺癌，CANT1】.
[18] Journal of Cancer. (IF=3.3). Huaxiang Wang, et al. (2022). The diagnostic and prognostic significance of small nuclear ribonucleoprotein Sm D1 aberrantly high expression in hepatocellular carcinoma. 【siRNA，miRNA，雙熒光素酶報(bào)告質(zhì)粒┃肝細(xì)胞癌，核糖核蛋白】.
[19] PLoS One. (IF=2.9). Jingwen Xiao, et al. (2022). MiRNA-1202 promotes the TGF-β1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS. 【miRNA mimics和miRNA inhibitor┃心臟纖維化】.
[20] European Journal of Medical Research. (IF=2.8). Jie Liu, et al. (2024). MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers. 【THP-1細(xì)胞┃MDM4，腫瘤免疫】.
[21] Journal of Orthopaedic Surgery and Research. (IF=2.8). Yuan Lin, et al. (2022). Inhibiting KCNMA1-AS1 promotes osteogenic differentiation of HBMSCs via miR-1303/cochlin axis. 【RNAi慢病毒┃成骨分化】.
[22] Journal of Cancer Research and Clinical Oncology. (IF=2.7). Yan Zhang, et al. (2024). Prognostic implications of TOR1B expression across cancer types: a focus on basal-like breast cancer and cellular adaptations to hypoxia. 【RNAi慢病毒┃乳腺癌，低氧適應(yīng)】.
[23] Journal of Clinical Laboratory Analysis. (IF=2.6). Yingfeng Jiang, et al. (2022). High expression of DARS2 indicates poor prognosis in lung adenocarcinoma. 【siRNA┃肺腺癌，預(yù)后】.
[24] Experimental and Therapeutic Medicine. (IF=2.4). Changlong Fu, et al. (2022). Protective role of Achyranthes bidentata polysaccharides against chondrocyte extracellular matrix degeneration through lncRNA GAS5 in osteoarthritis. 【RNAi慢病毒┃骨關(guān)節(jié)炎】.
[25] Open Medicine (Warsaw). (IF=1.7). Lijuan Ke, et al. (2022). miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/β-catenin pathway. 【miRNA mimics和miRNA inhibitor┃宮頸癌】.
